Source

Diabetology & Metabolic Syndrome

3 developments in the corpus

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Risk factors for metabolic syndrome: an umbrella review of systematic reviews and meta-analyses

Diabetology & Metabolic Syndrome

A systematic umbrella review of 72 meta-analyses synthesizing evidence from 7,367 articles on 101 risk factors for metabolic syndrome, providing comprehensive pooled estimates with confidence intervals and heterogeneity assessment.

Strong EvidenceQiaoxin Zhang Wenjing Xiong Yu Chen

Reported

MetS global prevalence20–30% of adults

Meta-analyses included72

Unique articles reviewed7,367

AUG 10, 2026 · JOURNAL ARTICLE

Association of glucagon-like peptide-1 receptor agonist therapy with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Diabetology & Metabolic Syndrome

Meta-analysis of six observational cohort studies showing a statistically significant 26% lower hazard of AF recurrence with GLP-1RA therapy, but low certainty of evidence and lack of randomized data limit strength.

PromisingMatin Varmazyar Parnia Jochin Diabetes Treatment and Management

Reported

Primary endpoint: Hazard ratio fo…0.74

95% Confidence interval0.63–0.87

Heterogeneity (I²)50.5%

AUG 6, 2026 · JOURNAL ARTICLE

Endocrine and metabolic profiling of PMOS rat models in relation to clinical obese and non-obese phenotypes

Diabetology & Metabolic Syndrome

Systematic comparison of three rat models against clinical PMOS features, but uncontrolled animal work with small per-group samples (n=8) and no between-model statistical testing reported; provides descriptive phenotypic characterization to guide model selection rather than a testable clinical or mechanistic finding.

PreliminaryHeqiu Yan Li Wang Fengjuan Zhang

Reported

Clinical PMOS cohort size110

Healthy control cohort size100

Let model group size (n per group)8